Article Listing - Eli Lilly outlines innovation strategy, sets 2010 financial guidance, but disappoints Wall Street

GLOBAL MARKETS AND FACTORS FOR SUCCESS

6 April 1992

As the geographical borders between pharmaceutical markets begin to disappear, so do the differences among the critical success factors for...

HERBAL MEDICINES IN ASIA 1992-96

6 April 1992

The international management consulting company McAlpine Thorpe and Warrier Ltd, which specializes in the field of herbal medicines, has announced...

STOCK MARKET COMMENTARY: EUROPE

6 April 1992

EUROPE: saw most bourses weak at the start of the reporting period, but strengthen as time went on. By the...

REDUCING ASTHMA COSTS IN THE USA

6 April 1992

A study looking at the economic aspect of asthma in the USA has found that there are a number of...

APPOINTMENTS AT AKZO

6 April 1992

Akzo NV of the Netherlands has appointed Lodewijk van Wachem and Abraham Cohen as members of its supervisory board.

PA CONSULTING GROUP APPOINTMENTS

6 April 1992

Appointed as senior associates for the pharmaceutical industry at PA Consulting Group are Keith Mansford, former chairman of R&D...

FURTHER FALLS FOR DEPRENYL?

6 April 1992

Shares of the Canadian biopharmaceutical company Deprenyl Re-search have recently lost value and could well fall further, according to local...

AUSTRALIAN DRUG PROMOTION STUDY

6 April 1992

In Australia, a parliamentary report from the House of Representatives concludes that there is no evidence that hospitality provided...

SANDOZ 1991 EARNINGS JUMP 15%

6 April 1992

Swiss pharmaceutical major Sandoz reported a 15% rise in net profit to 1.11 billion Swiss frances ($732.0 million) for 1991,...

BETA BLOCKERS AND DEPRESSION

6 April 1992

Commonly prescribed beta blockers used to treat conditions such as hypertension, angina and migraine do not cause depression, according to...

Showing 94531-94540 of 95365 articles

Go to beginningPreviousNextGo to end